Monsanto Halts Its Bid to Buy Rival Syngenta—For Now

<a href="http://www.shutterstock.com/gallery-320989p1.html?cr=00&pl=edit-00">360b</a> / <a href="http://www.shutterstock.com/editorial?cr=00&pl=edit-00">Shutterstock.com</a>

Facts matter: Sign up for the free Mother Jones Daily newsletter. Support our nonprofit reporting. Subscribe to our print magazine.


After four months of hot pursuit, genetically modified seed/pesticide giant Monsanto formally ended its bid to buy rival Syngenta Wednesday—at least for now. Earlier in the week, Monsanto had sweetened its offer for the Swiss agrochemical behemoth—most famous for its controversial atrazine herbicide and neonicotinoid pesticides—to $47 billion, in an effort to convince Syngenta’s management and shareholders to accept the merger. They balked, and Monsanto management opted to halt the effort, declaring in a press release that it would instead “focus on its growth opportunities built on its existing core business to deliver the next wave of transformational solutions for agriculture.” 

However, Monsanto may just be pausing, not fully halting, its buyout push. The company’s press release states that it’s “no longer pursuing [the] current proposal” (emphasis added) to buy its rival, and quickly added that the combination “would have created tremendous value for shareowners of both companies and farmers.” And as Dow Jones’ Jacob Bunge notes, Monsanto CEO Hugh Grant “has coveted Syngenta since at least 2011, and said in a June interview that he viewed the effort as ‘a long game.'” 

The logic that has driven Monsanto’s zeal for a deal remains in place: It wants to diversify away from its reliance on seeds by buying Syngenta, the world’s biggest purveyor of pesticides (more on that here). 

Meanwhile, Monsanto has been actively hyping up a new generation of pesticides, still in the development stage, which work by killing crop-chomping pests by silencing certain genes. But the company doesn’t expect the novel sprays to hit the market until 2020—a timeline that may be overly optimistic, as I show here

THE TRUTH...

is the first thing despots go after. An unwavering commitment to it is probably what draws you to Mother Jones' journalism. And as we're seeing in the US and the world around, authoritarians seek to poison the discourse and the way we relate to each other because they can't stand people coming together around a shared sense of the truth—it's a huge threat to them.

Which is also a pretty great way to describe Mother Jones' mission: People coming together around the truth to hold power accountable.

And right now, we need to raise about $400,000 from our online readers over the next two months to hit our annual goal and make good on that mission. Read more about the information war we find ourselves in and how people-powered, independent reporting can and must rise to the challenge—and please support our team's truth-telling journalism with a donation if you can right now.

payment methods

THE TRUTH...

is the first thing despots go after. An unwavering commitment to it is probably what draws you to Mother Jones' journalism. And as we're seeing in the US and the world around, authoritarians seek to poison the discourse and the way we relate to each other because they can't stand people coming together around a shared sense of the truth—it's a huge threat to them.

Which is also a pretty great way to describe Mother Jones' mission: People coming together around the truth to hold power accountable.

And right now, we need to raise about $400,000 from our online readers over the next two months to hit our annual goal and make good on that mission. Read more about the information war we find ourselves in and how people-powered, independent reporting can and must rise to the challenge—and please support our team's truth-telling journalism with a donation if you can right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate